Article
Antiviral resistance and hepatitis B therapy #
1 May 2009
Abstract excerpt
The management of chronic hepatitis B currently rests with long-term therapy using oral nucleoside analogs. The major limitation of long-term therapy is antiviral resistance. Antiviral resistance is due to the high rate of mutations that can occur during hepatitis B virus (HBV) replication and the selection of these mutants due to a replication advantage in the presence of the antiviral agent. Indeed, high rates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
